Pradelli, Lorenzo, Sara Villa, and Giancarlo Castaman. “Albutrepenonacog Alfa (Idelvion®) for the Treatment of Italian Patients With Hemophilia B: A Budget Impact Model”. Farmeconomia. Health economics and therapeutic pathways 19, no. 1 (January 30, 2018). Accessed July 23, 2025. https://provafe.seedstm.com/index.php/FE/article/view/1328.